These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8396094)

  • 1. The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections.
    Girard AE; Cimochowski CR; Faiella JA
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():29-37. PubMed ID: 8396094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
    Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
    J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].
    Prado V; Romero J; Herrera N; Marinkovic K; Bustos R
    Rev Med Chil; 1993 Oct; 121(10):1128-34. PubMed ID: 8191116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.
    Girard AE; Girard D; English AR; Gootz TD; Cimochowski CR; Faiella JA; Haskell SL; Retsema JA
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1948-54. PubMed ID: 2830841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of increased azithromycin concentrations with phagocyte infiltration into sites of localized infection.
    Girard AE; Cimochowski CR; Faiella JA
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():9-19. PubMed ID: 8818842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
    Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
    Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections.
    Müller O
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():137-46. PubMed ID: 8396085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-inflammatory effects of erythromycin, clarithromycin, azithromycin and roxithromycin on histamine-induced otitis media with effusion in guinea pigs.
    Ersoy B; Aktan B; Kilic K; Sakat MS; Sipal S
    J Laryngol Otol; 2018 Jul; 132(7):579-583. PubMed ID: 29888693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis.
    Rouse MS; Steckelberg JM; Brandt CM; Patel R; Miro JM; Wilson WR
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1673-6. PubMed ID: 9257739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
    Gill CJ; Abruzzo GK; Flattery AM; Smith JG; Jackson J; Kong L; Wilkening R; Shankaran K; Kropp H; Bartizal K
    J Antibiot (Tokyo); 1995 Oct; 48(10):1141-7. PubMed ID: 7490222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
    Sakran W; Raz R; Colodner R; Keness Y
    Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. History of macrolide use in pediatrics.
    Klein JO
    Pediatr Infect Dis J; 1997 Apr; 16(4):427-31. PubMed ID: 9109154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin.
    King A; Bathgate T; Phillips I
    Clin Microbiol Infect; 2002 Feb; 8(2):85-92. PubMed ID: 11952721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo.
    Retsema JA; Girard AE; Girard D; Milisen WB
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():83-9. PubMed ID: 2154442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin. A review of its use in paediatric infectious diseases.
    Langtry HD; Balfour JA
    Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
    Bahal N; Nahata MC
    Ann Pharmacother; 1992 Jan; 26(1):46-55. PubMed ID: 1318761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic-resistant oral streptococci in dental patients susceptible to infective endocarditis.
    Longman LP; Pearce PK; McGowan P; Hardy P; Martin MV
    J Med Microbiol; 1991 Jan; 34(1):33-7. PubMed ID: 1990136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae.
    Ishida K; Kaku M; Irifune K; Mizukane R; Takemura H; Yoshida R; Tanaka H; Usui T; Suyama N; Tomono K
    Antimicrob Agents Chemother; 1994 Apr; 38(4):790-8. PubMed ID: 8031048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.